Article 1 to 2 out of 2 concerning Galantos Pharma GmbH
Galantos Pharma Receives Research Grant(05/29/2008) Expansion of technology platform Galantos Pharma GmbH announced that it has been granted EUR 366.000 from Investitions- und Strukturbank Rheinland-Pfalz (ISB) GmbH, the investment and economic development bank of the German federal state of Rheinland-Pfalz. The grant was awarded ...
Galantos Pharma Selects Candidate for Clinical Development in Alzheimer's Disease(03/28/2008) Milestone triggers payment of last tranche of Series B financing round Galantos Pharma GmbH, a biopharmaceutical company developing natural product derivatives to treat Alzheimer's disease (AD) announced that it has selected a candidate molecule, which is expected to move into clinical development in Alzheimer's ...
Top
